Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bamlanivimab
bamlanivimab
Feds stop sending Eli Lilly’s COVID-19 cocktail to Illinois on concerns of P.1 variant
Fierce Pharma
Thu, 05/13/21 - 11:56 pm
Eli Lilly
COVID-19
Illinois
FDA
antibodies
bamlanivimab
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Reuters
Fri, 04/16/21 - 09:48 am
Eli Lilly
FDA
antibodies
COVID-19
bamlanivimab
Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data
Endpoints
Mon, 03/29/21 - 10:52 am
Eli Lilly
GSK
Vir Biotechnology
VIR-7831
bamlanivimab
clinical trials
COVID-19
Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says
Endpoints
Wed, 03/17/21 - 11:34 pm
Eli Lilly
COVID-19
bamlanivimab
COVID-19 variants
Vir and GSK Team Up with Eli Lilly for Double Monoclonal Antibody Study
BioSpace
Wed, 01/27/21 - 11:32 am
Vir Biotechnology
Eli Lilly
GSK
VIR-7831
bamlanivimab
COVID-19
Eli Lilly announces 650,000 additional doses of bamlanivimab purchased by US government to treat Covid-19
Pharmaceutical Business Review
Thu, 12/3/20 - 10:51 am
Eli Lilly
antibodies
bamlanivimab
COVID-19
government contract
CVS to distribute newly authorized antibody therapy
MedCity News
Wed, 12/2/20 - 11:58 pm
CVS Health
COVID-19
monoclonal antibodies
bamlanivimab
How Effective Will Lilly’s Bamlanivimab be in the Battle Against COVID-19?
BioSpace
Mon, 11/16/20 - 10:08 am
Eli Lilly
bamlanivimab
LY-CoV555
COVID-19
antibodies